Sun Pharmaceuticals Industries plans to acquire an 85.1% stake in JSC Biosintez for a purchase consideration of $60m.

The acquisition will enable Sun Pharmaceuticals to gain local manufacturing capabilities in Russia and expand its presence in the Russian pharmaceutical market.

"The acquisition enables Allergan to develop novel treatments for Alzheimer’s disease."

Allergan plans to expand its CNS research and development (R&D) pipeline through its recent acquisition of a clinical-stage biopharmaceutical company named Chase Pharmaceuticals Corporation.

Cowen and Company acted as the financial advisers for the transaction.

The acquisition enables Allergan to develop novel treatments for Alzheimer’s disease.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.